Navigation Links
Education and Media Key to Improving HIV/AIDS Awareness and Knowledge Levels in Afghanistan, New InterMedia Report Says
Date:4/2/2008

network of local research partners and contacts and its rich data archive of more than 670 media and opinion surveys carried out over the past 15 years.

HIV and AIDS Awareness in Afghanistan is available by contacting InterMedia's Alex Wooley at 202-434-9332, wooleya@intermedia.org

Survey details: the InterMedia national survey covered seven geographical regions consisting of 34 provinces; 2,057 Afghan respondents 15 or older were surveyed in 60-minute face-to-face interviews conducted in respondents' homes. Range of error with a 95 percent confidence interval is +/-2.2 percent.


'/>"/>
SOURCE InterMedia
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Kelsey Grammer, Ben Stiller, Maroon 5 and The Roots Added to COMEDY CENTRALs(R) Live On-air Charity Special Night of Too Many Stars: An Overbooked Concert for Autism Education Hosted by Jon Stewart on Sunday April 13, at 8 p.m. ET
2. CVCTA Education Announces New LOW DOSE Initiative for CT Angiograms
3. Next Months HR in Healthcare(TM) Conference Promises to be Educational Destination for the Healthcare Industrys Senior HR Practitioners
4. New Study -- Same Result! Comprehensive Sex Education Works
5. National Health Education Tour to Kick-Off in Atlanta
6. Families Can Make Informed 2008 Presidential Campaign Decisions With FamilyEducation & Infoplease
7. Temple and Fox Chase partner on research and education
8. Commissions Revenue Cap Proposal Would Require Cuts in Education, Health, and Safety, and Harm Business Climate
9. Recession Proof Yourself With Education
10. New STD Data Shows Need for Abstinence Education, Says Family Research Council
11. Kidney Care Partners Encourages Policymakers to Support Increased Kidney Care Education and Disease Prevention Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)... The Palomino Group, a le... organization, today announced the launch of its n... to the biopharmaceutical industry. The company, b...ursement and commercialization consulting services...al device, and other healthcare companies. , ...
(Date:7/23/2008)... Output of New Molecular Entities Drops to Histori... Competition from Generics Companies, LONDON, Jul...omson,Reuters today announced the availability of ...eutical R&D Factbook, an indispensable reference,a...harmaceutical R&D,corporate finance, business str...
(Date:7/23/2008)... IVF clinic expands welcome to out-of-state...Newswire/ -- The recent California,Supreme Court d...the,commitment of the Reproductive Science Center ...fertility practices, to serving gays and lesbians ...ation of same-sex marriage supports RSC,s,long-hel...
(Date:7/23/2008)... Full line of vaccines for Immigration and Natural... Health, BALTIMORE, July 23 /PRNewswire/ -...is applying for an immigrant visa for entry into t...r permanent residence. Applicants,must show proof ...es, as,recommended by the U.S. Advisory Committee ...
Breaking Medicine News(10 mins):Health News:The Palomino Group Announces Launch of Meeting Support Services Business Unit 2Health News:The Palomino Group Announces Launch of Meeting Support Services Business Unit 3Health News:Thomson Reuters Publishes CMR International's 2008 Pharmaceutical R&D Factbook, Now Available for the First Time Online 2Health News:California Supreme Court Gay-Marriage Ruling Reinforces Top Bay Area Fertility Specialists' Support for Same-Sex Couples 2Health News:USCIS Tightens Vaccination Requirements 2
...cited scientists, even after twenty years of its i...me the evil ways of viruses, such as those involve...e (HIV). Scientists have realized there is one stu...ways towards the development of an effective trans...
...amme has been planned in Edmonton’s Capital Health... level of a person is recorded whenever he or she ...ediately stored in a central database. This inform...etes and treat the illness if found. If diabetes ...
...ertension means high pressure in the arteries. Hig... ‘ silent killer’ because one can have it for year...rmal BP when his blood pressure reading is around ...e with systolic reading between 130 and 139, and a...
...e's pharmaceutical giant, is finalizing its plan o...rix against Merck & Co.'s Gardasil, in a bid to es...l cancer. The study, which will be conducted in t...e the immune responses of women aged 18 to 26 year...
Other Medicine News:Health News:Researchers Explore the Effect of Engineered Immune Cells on HIV 2Health News:Researchers Explore the Effect of Engineered Immune Cells on HIV 3Health News:Slightly High Blood Pressure is Also Hazardous 2
(Date:7/23/2008)...ATTLE, July 23 /- Sound Pharmaceutica...lication with the FDA for the clinical,testing of ...ntion of,chemotherapy induced hearing loss or otot...3005, will be tested in advanced stage lung cancer...num based chemotherapy.,This marks the second deve...
(Date:7/23/2008)...ATTLE, July 23 /- Dendreon ...it expects the Independent Data,Monitoring Committ...alysis,of overall survival relating to the Company...oCarcinoma Treatment, also known as D9902B) clinic...s the Company,s investigational,active cellular im...
(Date:7/22/2008)...test awards under Therapeutics Development Initiat...tions to 23; next deadline January 20,2009, NEW ...f its mission to,speed delivery of transformative ... Michael J. Fox Foundation for Parkinson,s Researc... industry research teams. The awards,were granted ...
(Date:7/22/2008)... Geoffrey Allan Will Stress the Importance to Pati...gics Approval Pathway, RICHMOND, Va., July 22 /PR...M) a developer of follow-on biologics and biopharm...h.D., CEO of Insmed, will present at a,Congression...the,significant need for establishing an approval ...
Breaking Medicine Technology:Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Titanium Group to Attend Regional ICT Meeting in Thailand 3031 1Titanium Group to Attend Regional ICT Meeting in Thailand 3031 2Titanium Group to Attend Regional ICT Meeting in Thailand 3031 3Anadys Pharmaceuticals to Report First Quarter 2008 Financial Results 4823 1Anadys Pharmaceuticals to Report First Quarter 2008 Financial Results 4823 2Former Bristol Myers Squibb Senior Vice President Indicted for Lying to the Federal Government About Popular Blood Thinning Drug 17600 1Former Bristol Myers Squibb Senior Vice President Indicted for Lying to the Federal Government About Popular Blood Thinning Drug 17600 2Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 1Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 2Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 3Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 4Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 5Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 6Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 7Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 8Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 9Aflac Incorporated Announces First Quarter Results Declares Second Quarter Cash Dividend 17595 10
ISI Micro Brushes are available in a variety of French diameters. Made with stainless steel handles and nylon bristles, the ISI Micro Brushes will last through countless cleanings.
...tion to securely access patient information, image...rs can login from virtually anywhere with a secure...udies. , Secure web-based access to patient i...sired patient study with searchable fields, Supp...
Instra-Glide Target is the non-silicone lubricant designed to "spot" lubricate moving parts , ,Instra-Glide Target lubricates sticky pivot points, hinges, box joints and other moving parts. The pen
Shandon Excelsior ES Tissue Processor continues the Thermo Electron Corporation tradition of offering one of the most advanced, traditional reagent instruments available today.
Medicine Products: